EP Patent

EP0481443A1 — Transdermal therapeutic compositions

Assigned to Adare Pharmaceuticals SRL · Expires 1992-04-22 · 34y expired

What this patent protects

There are described transdermal therapeutic compositions showing an improved shelf stability of the chemical-physical structure of the medicament and particularly useful for its cutaneous administration, said compositions consisting of a supporting rigid sheet, a polymeric matrix…

USPTO Abstract

There are described transdermal therapeutic compositions showing an improved shelf stability of the chemical-physical structure of the medicament and particularly useful for its cutaneous administration, said compositions consisting of a supporting rigid sheet, a polymeric matrix and a protective removable sheet, wherein said polymeric matrix consists of a polymeric film in which there are distributed particles loaded with medicaments and agents promoting the cutaneous absorption.

Drugs covered by this patent

Patent Metadata

Patent number
EP0481443A1
Jurisdiction
EP
Classification
Expires
1992-04-22
Drug substance claim
No
Drug product claim
No
Assignee
Adare Pharmaceuticals SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.